Sutro Biopharma, Inc. (STRO) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est MOLINA ARTURO MD avec 37,500 actions. Parmi les autres détenteurs notables Freund John Gordon et NEWELL WILLIAM J.
Au cours des 12 derniers mois, les initiés ont effectué 44 transactions sur STRO l'action — 28 achats (d'une valeur de $796.23K) et 0 ventes (d'une valeur de RSU Award). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
STRO Participations des Initiés
Principal Actionnaire
MOLINA ARTURO MD
37,500 actions
Achats (12 mois)
28
$796.23K valeur
Ventes (12 mois)
0
$0.00 valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Molina Arturo Md |
Chief Medical Officer |
37,500 |
2022-03-07 |
|
| 2 |
Freund John Gordon |
Director |
35,000 |
2024-06-10 |
|
| 3 |
Newell William J |
CEO |
31,125 |
2025-03-06 |
|
| 4 |
Worsley Stephen |
Chief Business Officer |
30,000 |
2019-01-31 |
|
| 5 |
Lawlis V Bryan |
Director |
26,033 |
2018-09-27 |
|
| 6 |
Sharp Shalini |
Director |
18,500 |
2022-06-08 |
|
| 7 |
Borgman Anne Elizabeth |
Chief Medical Officer |
17,812 |
2025-05-05 |
|
| 8 |
Shabbir Anik |
Chief Technical Ops. Officer |
17,500 |
2023-03-07 |
|
| 9 |
Leyman Barbara |
Chief Business Officer |
16,056 |
2025-08-26 |
|
| 10 |
Albini Edward C |
CFO and Secretary |
15,750 |
2025-03-04 |
|
| 11 |
Shtylla Brunilda |
Chief Business Officer |
12,928 |
2023-08-28 |
|
| 12 |
Janney Daniel |
Director |
11,610 |
2019-06-19 |
|
| 13 |
Fitzpatrick Linda A |
Chief People & Comm. Officer |
9,125 |
2025-03-06 |
|
| 14 |
Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
7,500 |
2023-04-17 |
|
| 15 |
Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
6,500 |
2023-07-13 |
|
| 16 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
5,000 |
2025-05-05 |
|
| 17 |
Chow Gregory K. |
CFO |
5,000 |
2026-03-03 |
|
| 18 |
Ross Michael Jay |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 19 |
Svlsf V, Llc |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 20 |
Gerber Hans-peter |
Chief Scientific Officer |
2,250 |
2026-03-03 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-03-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Exercice d'Options (Vente) |
675 |
- |
- |
| 2026-03-04 |
Chung Jane |
Chief Executive Officer |
Exercice d'Options (Vente) |
788 |
- |
- |
| 2026-03-02 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Attribution de RSU |
4,200 |
- |
- |
| 2026-03-01 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Exercice d'Options (Vente) |
500 |
- |
- |
| 2026-03-02 |
Gerber Hans-peter |
Chief Scientific Officer |
Attribution de RSU |
5,000 |
- |
- |
| 2026-03-01 |
Gerber Hans-peter |
Chief Scientific Officer |
Exercice d'Options (Vente) |
1,125 |
- |
- |
| 2026-03-02 |
Chung Jane |
Chief Executive Officer |
Retenue Fiscale RSU |
2,779 |
$20.55 |
$57.11K |
| 2026-03-01 |
Chung Jane |
Chief Executive Officer |
Exercice d'Options (Vente) |
688 |
- |
- |
| 2026-03-02 |
Chow Gregory K. |
CFO |
Attribution de RSU |
5,000 |
- |
- |
| 2025-12-23 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Attribution de RSU |
7,200 |
$10.38 |
$74.74K |
| 2025-12-23 |
Gerber Hans-peter |
Chief Scientific Officer |
Attribution de RSU |
7,925 |
$10.38 |
$82.26K |
| 2025-12-23 |
Hunter Heidi |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Chow Gregory K. |
CFO |
Attribution de RSU |
8,200 |
$10.38 |
$85.12K |
| 2025-12-23 |
Dybbs Michael |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Wigginton Jon Marc |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Jagpal Sukhi |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Lobacki Joseph M |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Petree Daniel H |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Matsui Connie |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Panek James P |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-12 |
Chung Jane |
Chief Executive Officer |
Exercice d'Options (Vente) |
2,500 |
- |
- |
| 2025-10-15 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Achat Informatif |
12,504 |
$0.80 |
$9.99K |
| 2025-10-15 |
Gerber Hans-peter |
Chief Scientific Officer |
Achat Informatif |
17,000 |
$0.80 |
$13.61K |
| 2025-10-15 |
Chung Jane |
Chief Executive Officer |
Achat Informatif |
12,500 |
$0.80 |
$10.01K |
| 2025-10-15 |
Chow Gregory K. |
CFO |
Achat Informatif |
19,750 |
$0.81 |
$16K |
Les autres consultent aussi